Procept BioRobotics [PRCT] vs Abbott Laboratories [ABT] Detailed Stock Comparison

Procept BioRobotics Corporation

NASDAQ
Loading...

Abbott Laboratories

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Procept BioRobotics Corporation wins in 2 metrics, Abbott Laboratories wins in 17 metrics, with 0 ties. Abbott Laboratories appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Procept BioRobotics Corporation Abbott Laboratories Better
P/E Ratio (TTM) -14.09 25.97 Abbott Laboratories
Price-to-Book Ratio 3.86 3.09 Abbott Laboratories
Debt-to-Equity Ratio 21.45 26.79 Procept BioRobotics Corporation
PEG Ratio -0.27 -1.41 Procept BioRobotics Corporation
EV/EBITDA -12.39 13.74 Abbott Laboratories
Profit Margin (TTM) -31.02% 13.90% Abbott Laboratories
Operating Margin (TTM) -40.64% 16.50% Abbott Laboratories
EBITDA Margin (TTM) N/A 16.50% N/A
Return on Equity -24.89% 12.36% Abbott Laboratories
Return on Assets (TTM) -12.46% 7.52% Abbott Laboratories
Free Cash Flow (TTM) $-58.34M $7.40B Abbott Laboratories
Dividend Yield 0.64% 1.97% Abbott Laboratories
1-Year Return -54.60% -35.92% Abbott Laboratories
Price-to-Sales Ratio (TTM) 4.59 3.57 Abbott Laboratories
Enterprise Value $1.21B $166.96B Abbott Laboratories
EV/Revenue Ratio 3.92 3.70 Abbott Laboratories
Gross Profit Margin (TTM) 60.63% N/A N/A
Revenue per Share (TTM) $6 $26 Abbott Laboratories
Earnings per Share (Diluted) $-1.72 $3.57 Abbott Laboratories
Beta (Stock Volatility) 0.93 0.78 Abbott Laboratories
Short % of Float 12.30% 1.53% Abbott Laboratories

Procept BioRobotics Corporation vs Abbott Laboratories Stock Performance Analysis

Loading Price Chart...

PRCT
ABT

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Procept BioRobotics Corporation-1.61%-0.49%6.04%0.27%-20.64%-14.40%
Abbott Laboratories0.02%1.53%-0.63%-23.43%-30.57%-29.95%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Procept BioRobotics Corporation-54.60%-18.98%-34.18%-34.18%-34.18%-34.18%
Abbott Laboratories-35.92%-17.85%-21.68%118.48%249.25%313.73%

Performance & Financial Health Analysis: Procept BioRobotics Corporation vs Abbott Laboratories

MetricPRCTABT
Market Information
Market Cap i$1.37B$160.70B
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i961,94213,495,583
90 Day Avg. Volume i1,216,34712,934,461
Last Close$26.33$86.99
52 Week Range$19.35 - $66.85$81.97 - $139.06
% from 52W High-60.61%-37.44%
All-Time High$103.81 (Nov 11, 2024)$142.60 (Dec 27, 2021)
% from All-Time High-74.64%-39.00%
Growth Metrics
Quarterly Revenue Growth0.12%0.08%
Quarterly Earnings Growth0.12%-0.19%
Financial Health
Profit Margin (TTM) i-0.31%0.14%
Operating Margin (TTM) i-0.41%0.17%
Return on Equity (TTM) i-0.25%0.12%
Debt to Equity (MRQ) i21.4526.79
Cash & Liquidity
Book Value per Share (MRQ)$6.50$30.02
Cash per Share (MRQ)$5.08$5.14
Operating Cash Flow (TTM) i$-48,985,000$10.80B
Levered Free Cash Flow (TTM) i$-23,916,124$13.77B
Dividends
Last 12-Month Dividend Yield i0.64%1.97%
Last 12-Month Dividend i$0.38$2.40

Valuation & Enterprise Metrics Analysis: Procept BioRobotics Corporation vs Abbott Laboratories

MetricPRCT (Apr 24, 2026)ABT (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i-14.0925.97
Forward P/E i-28.3815.29
PEG Ratio i-0.27-1.41
Price to Sales (TTM) i4.593.57
Price to Book (MRQ) i3.863.09
Market Capitalization
Market Capitalization i$1.37B$160.70B
Enterprise Value i$1.21B$166.96B
Enterprise Value Metrics
Enterprise to Revenue i3.923.70
Enterprise to EBITDA i-12.3913.74
Risk & Other Metrics
Beta i0.930.78
Book Value per Share (MRQ) i$6.50$30.02

Financial Statements Comparison: Procept BioRobotics Corporation vs Abbott Laboratories

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricPRCT (2025)ABT (2025)
Revenue/Sales i308.05M44.33B
Cost of Goods Sold i111.83M19.32B
COGS % of Revenue i36.3%43.6%
Gross Profit i196.23M25.01B
Gross Margin i63.7%56.4%
Research & Development i71.28M2.94B
Operating Income (EBIT) i-103.86M8.05B
Operating Margin i-33.7%18.2%
EBITDA i-85.41M12.03B
EBITDA Margin i-27.7%27.1%
Pre-Tax Income i-95.38M8.47B
Pre-Tax Income % of Revenue i-31.0%19.1%
Income Tax i190,0001.94B
Income Tax % of Revenue i0.1%4.4%
Net Income (Profit) i-95.57M6.52B
Profit Margin i-31.0%14.7%

Balance Sheet & Liquidity Metrics

MetricPRCT (2025)ABT (2025)
Cash & Equivalents i286.50M8.52B
Total Current Assets i450.38M26.00B
Total Current Assets % of Revenue i146.2%58.6%
Total Current Liabilities i65.80M16.50B
Total Current Liabilities % of Revenue i21.4%37.2%
Long-Term Debt i76.27M10.83B
Long-Term Debt % of Revenue i24.8%24.4%
Total Shareholders Equity i365.87M52.77B
Retained Earnings i-641.56M49.78B
Retained Earnings % of Revenue i-208.3%112.3%
Property, Plant & Equipment i21.51M17.57B

Cash Flow Statement Comparison

MetricPRCT (2025)ABT (2025)
Operating Cash Flow i-50.56M10.80B
Operating Cash Flow % of Revenue i-16.4%24.4%
Capital Expenditures i-9.36M-2.17B
Free Cash Flow i-58.34M7.40B
FCF Margin i-18.9%16.7%
Debt Repayment iN/A-1.50B
Common Stock Repurchase iN/A-893.00M

Short Interest & Institutional Ownership Analysis

MetricPRCTABT
Shares Short i5.87M23.83M
Short Ratio i3.251.93
Short % of Float i12.30%1.53%
Shares Outstanding i56.32M1.74B
Float Shares i55.12M1.73B
% Held by Insiders i3.22%0.54%
% Held by Institutions i104.61%82.23%
% Held by Public i-7.83%17.23%

Dividend Analysis & Yield Comparison: Procept BioRobotics Corporation vs Abbott Laboratories

MetricPRCTABT
Last 12-Month Dividend i$0.38$2.40
Last 12-Month Dividend Yield i0.64%1.97%
3-Year Avg Annual Dividend i$0.53$2.24
3-Year Avg Dividend Yield i0.12%0.50%
3-Year Total Dividends i$1.59$6.72
Ex-Dividend DateMar 31, 2025Jan 15, 2026